Short-Term Effect Of Ceriter Stride One (CSO) on FOG and Falling in pwP
CSO_FOG
Exploration of the Short-term Effects and User Satisfaction of the Ceriter Stride One (CSO) Regarding the Prevention and Treatment of Freezing or Gait in Persons With Parkinson's Disease (pwP).
1 other identifier
interventional
11
1 country
1
Brief Summary
The Ceriter Stride One (CSO) is a "smart sole" with pressure sensors. The sole allows data on the displacement of the body's centre of gravity (COG), as well as spatiotemporal parameters, to be obtained via pressure recordings. Logarithms, released on the data captured by the sole, make it possible to recognise propulsion (forward movement of the CG), accompanied by a reduction in step length (festination) or feet remaining standing (freezing of gait). When the system registers incipient propulsion, an audio signal ("stop") is generated via an audio device and app on the mobile phone. The CSO aims to make the pwP stop before balance disturbance can occur, preventing further propulsion and falls. The aim of the study is to explore the short-term effects of the CSO in terms of reducing (preventing) freezing of gait and fall risk in a pilot group of pwP whose functionality is limited (Hoehn and Yahr 4). Short-term impact on gait (episodes of freezing of gait, mean step length, mean gait speed) will be evaluated and user satisfaction surveyed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2023
CompletedStudy Start
First participant enrolled
December 5, 2023
CompletedFirst Posted
Study publicly available on registry
January 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2024
CompletedJune 5, 2024
June 1, 2024
5 months
December 1, 2023
June 4, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
The number of captured episodes with freezing of gait (FOG)
n (number of captured FOG-episodes : the less, the better)
2 times 3 minutes
The number of captured steps
n (number - more steps relate to a better mobility)
2 times 3 minutes
The difference between the pressure of steps with left versus right foot; as a measure of gait asymmetry.
mean presure data of left foot versus mean pressure data of right foot
2 times 3 minutes
mean step length
mean step length (cm)
2 times 3 minutes
Secondary Outcomes (1)
users satisfaction
after testing (5 min)
Study Arms (1)
persons with Parkinson's Disease, Hoehn & Yahr stage 4, FOG
EXPERIMENTALThis group tests first without the use of cues (CSO evaluates gait pattern, but does not adjust), and then with cues.
Interventions
The sole is worn without using the cueing application
The sole is worn with using the cueing application
Eligibility Criteria
You may qualify if:
- Parkinson's disease (or other Parkinsonism)
- gait impairment with freezing of gait (FOG)
- years old
- I.C. (informed consent)
- Montreal Cognitive Assessment (MoCA) \>25
You may not qualify if:
- unable to walk 4m without assistance
- MoCA \< 25
- no FOG
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
Ghent University
Ghent, Oost-Vlaanderen, 9000, Belgium
Related Publications (1)
Zoetewei D, Herman T, Brozgol M, Ginis P, Thumm PC, Ceulemans E, Decaluwe E, Palmerini L, Ferrari A, Nieuwboer A, Hausdorff JM. Protocol for the DeFOG trial: A randomized controlled trial on the effects of smartphone-based, on-demand cueing for freezing of gait in Parkinson's disease. Contemp Clin Trials Commun. 2021 Jun 29;24:100817. doi: 10.1016/j.conctc.2021.100817. eCollection 2021 Dec.
PMID: 34816053RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dirk Cambier, PhD
UGent, FGE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2023
First Posted
January 12, 2024
Study Start
December 5, 2023
Primary Completion
May 14, 2024
Study Completion
May 14, 2024
Last Updated
June 5, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share